That doesn't signify they aren't thinking of it. Various breakthrough therapy designations are actually granted for psilocybin from the treatment of resistant depression—that is, depression that does not respond to at the least two different types of antidepressants—and a broader approval could possibly be on the horizon.Members who microdosed